Literature DB >> 6691045

Use of pneumococcal polysaccharide vaccine in preventing otitis media in infants: different results between racial groups.

V M Howie, J Ploussard, J L Sloyer, J C Hill.   

Abstract

A total of 133 children between 6 and 11 months of age with at least one episode of otitis media were given one of two pneumococcal vaccines. One vaccine contained 25 microns of types 1, 3, 6, 7, 14, 18, 19, and 23 and the other vaccine (control) contained 25 microns of types 2, 4, 5, 8, 9, 12, and 25. Follow-up care of the 65 black infants revealed significantly more otitis media visits in those infants receiving the control vaccine. Among the 68 white infants there was no difference between control and vaccine groups after vaccination.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6691045

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

Review 1.  Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.

Authors:  Q Zhang; A Finn
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

Review 2.  Periodic health examination, 1991 update: 2. Administration of pneumococcal vaccine. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-03-15       Impact factor: 8.262

Review 3.  Advances in pneumococcal vaccines: advantages for infants and children.

Authors:  Jolanta Bernatoniene; Adam Finn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Otitis media with effusion: is medical management an option?

Authors:  P Burke
Journal:  J R Coll Gen Pract       Date:  1989-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.